|Bid||200.14 x 1000|
|Ask||200.96 x 1000|
|Day's Range||195.61 - 202.86|
|52 Week Range||141.41 - 207.00|
|Beta (5Y Monthly)||0.64|
|PE Ratio (TTM)||54.51|
|Forward Dividend & Yield||1.00 (0.49%)|
|Ex-Dividend Date||Jul 20, 2021|
|1y Target Est||N/A|
Zoetis (ZTS) delivered earnings and revenue surprises of 10.19% and 6.30%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Zoetis Inc. reported Thursday second-quarter profit and revenue that rose above expectations and lifted its full-year outlook, driven by petcare parasiticides, dermatology products, vaccines and diagnostics. The animal health company's stock slipped 0.4% in premarket trading, after closing Wednesday at a record. Net income rose to $512 million, or $1.07 a share, from $377 million, or 79 cents a share, in the year-ago period. Excluding nonrecurring items, adjusted earnings per share came to $1.19
Zoetis exceeded Q2 earnings and revenue estimates. Shares of the animal-health giant were little changed.